The Effect of Intraamygdalar Leptin Administration on Anxiety, Depression and Learning Behaviors in Rats

Abstract

Leptin is released by adipose tissue. Leptin can cross the blood–brain barrier and bind to receptors on neurons in brain areas to exert its biological function when released into circulation. This study aimed to determine the influences of intraamygdalar administration of high and low doses of leptin on anxiety, depression, learning behaviors of rats. In the experimental protocol I, intraamygdalar injection of high and low doses of leptin (0.1 and 1 μg/ kg) and saline were administered 30 min before the behavioral tests. Then, the animals were exposed to open field, elevated plus maze, Porsolt and Morris water maze tests for measuring of behaviors. In experimental protocol 2, the cerebrospinal fluids of all groups of experimental protocol 1 were collected by microdialysis method and then were analyzed by HPLC.The effect of the low dose of leptin was significant on the open field. The effect of the high and low dose of leptin was significant on the elevated plus maze test. The effect of the low dose of leptin was significant on mobility in the center of the Porsolt. A high dose of leptin group had spent less time around the platform than controls in the Morris water maze test. HPLC analysis showed that the amount of serotonin and glutamate in the amygdala region increased after low dose leptin administration. Intraamygdalar injection of low doses of leptin may decrease anxiety and depression-like behavior in rats by increasing serotonin and glutamate levels in the amygdala.

Keywords

• Leptin
• Behaviors
• amygdala
• anxiety
• depression
• Learning

References

1. Banks, A. S., Davis, S. M., Bates, S. H., & Myers, M. G., Jr.,2000. Activation of downstream signals by the long form of the leptin receptor. The Journal of biological chemistry, 275(19), 14563–14572. https://doi.org/10.1074/jbc.275.19.14563
2. Berridge, K. C., & Kringelbach, M. L.,2015. Pleasure systems in the brain. Neuron, 86(3), 646–664. https://doi.org/10.1016/j.neuron.2015.02.018 Canli T, Omura K, Haas BW Fallgatter A, Constable RT, Lesch KP., Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. PNAS. 2005;102:12224-29.
3. De Kloet, E. R., Joëls, M., & Holsboer, F.,2005. Stress and the brain: from adaptation to disease. Nature reviews. Neuroscience, 6(6), 463–475. https://doi.org/10.1038/nrn1683
4. Esel, E., Ozsoy, S., Tutus, A., Sofuoglu, S., Kartalci, S., Bayram, F., Kokbudak, Z., & Kula, M.,2005. Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression. Progress in neuro-psychopharmacology & biological psychiatry, 29(4), 565–570. https://doi.org/10.1016/j.pnpbp.2005.01.009
5. Farr, S. A., Banks, W. A., & Morley, J. E., 2006. Effects of leptin on memory processing. Peptides, 27(6), 1420–1425. https://doi.org/10.1016/j.peptides.2005.10.006
6. Havel P. J., 2000. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. The Proceedings of the Nutrition Society, 59(3), 359–371. https://doi.org/10.1017/s0029665100000410
7. Heiman, M. L., Ahima, R. S., Craft, L. S., Schoner, B., Stephens, T. W., & Flier, J. S.,1997. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology, 138(9), 3859–3863. https://doi.org/10.1210/endo.138.9.5366
8. Hastings, R.P.,2002. Parental stress and behaviour problems of children with developmental disability. J Intellect Dev Disabil.;27:149-160. Jow GM, Yang TT, Chen CL., 2006. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. Journal of Affective Disorders. 90(1):21-27. DOI: 10.1016/j.jad.2005.09.015.

9. Kanoski, S. E., & Davidson, T. L.,2011. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiology & behavior, 103(1), 59–68. https://doi.org/10.1016/j.physbeh.2010.12.003
10. Krishnan, V., & Nestler, E. J., 2010. Linking molecules to mood: new insight into the biology of depression. The American journal of psychiatry, 167 (11), 1305–1320. https://doi.org/10.1176/appi.ajp.2009.10030434
11. Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D., Koethe, D., & Pollmächer, T., 2002. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry, 35(6), 220–225. https://doi.org/10.1055/s-2002-36390
12. Kurhe, Y., Mahesh, R., & Devadoss, T ., 2015. QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice. Biochemical and biophysical research communications, 456(1), 74–79. https://doi.org/10.1016/j.bbrc.2014.11.036
13. Liu, T., Yuan, Z., Sun, J., Wang, J., Zheng, N., Tang, X., & Shum, H. Y., 2011. Learning to detect a salient object. IEEE transactions on pattern analysis and machine intelligence, 33(2), 353–367. https://doi.org/10.1109/TPAMI.2010.70
14. Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., Wiggins, J. F., Bader, A. G., Fagin, R., Brown, D., & Tang, D. G., 2011. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature medicine, 17(2), 211–215. https://doi.org/10.1038/nm.2284
15. Lu, A. H., Salabas, E. L., & Schüth, F.,2007. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angewandte Chemie (International ed. in English), 46(8), 1222–1244. https://doi.org/10.1002/anie.200602866
16. Liu, J., Guo, M., & Lu, X. Y.,2015. Leptin/LepRb in the Ventral Tegmental Area Mediates Anxiety-Related Behaviors. The international journal of neuropsychopharmacology, 19(2), pyv115. https://doi.org/10.1093/ijnp/pyv115
17. Patterson P. H., 2011. Maternal infection and immune involvement in autism. Trends in molecular medicine, 17(7), 389–394. https://doi.org/10.1016/j.molmed.2011.03.001
18. Pasco, J. A., Williams, L. J., Jacka, F. N., Ng, F., Henry, M. J., Nicholson, G. C., Kotowicz, M. A., & Berk, M.,2008. Tobacco smoking as a risk factor for major depressive disorder: population-based study. The British journal of psychiatry : the journal of mental science, 193(4), 322–326. https://doi.org/10.1192/bjp.bp.107.046706
19. Paulus, K., Schulz, C., & Lehnert, H.,2005. Central nervous effects of leptin and insulin on hippocampal leptin and insulin receptor expression following a learning task in Wistar rats. Neuropsychobiology, 51(2), 100–106. https://doi.org/10.1159/000084167
20. Reseland JE, Mundal HH, Hollung K, et al.,2005. Cigarette smoking may reduce plasma leptin concentration via catecholamines. Prostaglandins, Leukotrienes, and Essential Fatty Acids. Jul;73(1):43-49. DOI: 10.1016/j.plefa.2005.04.006.
21. Rubin, K. H., Burgess, K. B., & Hastings, P. D.,2002. Stability and social-behavioral consequences of toddlers' inhibited temperament and parenting behaviors. Child development, 73(2), 483–495. https://doi.org/10.1111/1467-8624.00419
22. Romanova, I. V., Derkach, K. V., Mikhrina, A. L., Sukhov, I. B., Mikhailova, E. V., & Shpakov, A. O.,2018. The Leptin, Dopamine and Serotonin Receptors in Hypothalamic POMC-Neurons of Normal and Obese Rodents. Neurochemical research, 43(4), 821–837. https://doi.org/10.1007/s11064-018-2485-z
23. Sharma, A. N., Elased, K. M., Garrett, T. L., & Lucot, J. B.,2010. Neurobehavioral deficits in db/db diabetic mice. Physiology & behavior, 101(3), 381–388. https://doi.org/10.1016/j.physbeh.2010.07.002
24. Schilling, T. M., Kölsch, M., Larra, M. F., Zech, C. M., Blumenthal, T. D., Frings, C., & Schächinger, H.,2013. For whom the bell (curve) tolls: cortisol rapidly affects memory retrieval by an inverted U-shaped dose-response relationship. Psychoneuroendocrinology, 38(9), 1565–1572. https://doi.org/10.1016/j.psyneuen.2013.01.001
25. Tecott, L. H., Maricq, A. V., & Julius, D.,1993. Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proceedings of the National Academy of Sciences of the United States of America, 90(4), 1430–1434. https://doi.org/10.1073/pnas.90.4.1430
26. Yu, W. H., Kimura, M., Walczewska, A., Karanth, S., & McCann, S. M.,1997. Role of leptin in hypothalamic-pituitary function. Proceedings of the National Academy of Sciences of the United States of America, 94(3), 1023–1028. https://doi.org/10.1073/pnas.94.3.1023
27. Zarrindast, M. R., & Khakpai, F.,2015. The Modulatory Role of Dopamine in Anxiety-like Behavior. Archives of Iranian medicine, 18(9), 591–603.
28. Zhang, Y., Proenca, R., Maffei, M. et al.,1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 https://doi.org/10.1038/372425a0
29. Zeman, M., Szántóová, K., Stebelová, K., Mravec, B., & Herichová, I., 2009. Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR (mRen2)27 rats. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 27(6), S21–S26. https://doi.org/10.1097/01.hjh.0000358833.41181.f6